Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic drug monitoring in depression.

Polish journal of pharmacology - 1 Jan 2000

Radziwoń-Zaleska M, Matsumoto H, Skalski M, Androsiuk W, Dziklińska A, Kunicki P K

Abstract excerpt

The difference between Therapeutic Drug Monitoring (TDM) and uncontrolled therapy consists in the fact that in TDM we can predict a certain scheme of treatment according to clinical and laboratory results. It is a method which serves to increase the efficacy and safety of pharmacotherapy in an individual patient. This paper presents the results of the treatment with tricyclic antidepressants based on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antidepressive Agents
Share to Debrisoquin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Depressive Disorder

Share to Drug Monitoring

Share to Electroencephalography

Share to Prognosis

Share to Psychiatric Status Rating Scales

Source

Identifiers

PMID: 11345481

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic drug monitoring in depression.PMID 11345481Read ↗

[Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].Semantic proximity Read ↗

The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.Semantic proximity Read ↗

Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.Semantic proximity Read ↗

[Debrisoquine hydroxylation test as an example of new possibilities of research in psychopharmacology].Semantic proximity Read ↗

Debrisoquine and dextromethorphan phenotyping and antidepressant treatment.Semantic proximity Read ↗

[Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].Semantic proximity Read ↗

QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.Semantic proximity Read ↗

CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects.Semantic proximity Read ↗

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.Semantic proximity Read ↗

Pharmacogenetics of desipramine metabolism.Semantic proximity Read ↗

Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.Semantic proximity Read ↗

Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.